Catalyst Wire Dossier Catalyst Wire Dossier

AFX3772 vaccine

AFX3772 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFX3772 vaccine, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants [Phase 2]

See pricing